Vitamin D Role in Prevention of Cancer: Overview

Abstract

Vitamin D is the name given to a group of fat-soluble prohormones. Two major forms of Vitamin D that are important to humans are Vitamin D2 or ergocalciferol and Vitamin D3 or cholecalciferol. Vitamin D2 is made naturally by the body when the skin is exposed to ultraviolet radiation (in particular, ultraviolet B [UVB] radiation) in sunlight. Vitamin D2 and Vitamin D3 can also be commercially manufactured. The active form of Vitamin D in the body is 1,25-dihydroxyvitamin D or calcitriol, which can be made from either Vitamin D2 or Vitamin D3. Evidence suggests that Vitamin D helps in the prevention of various cancers such as breast cancer, colorectal cancer, prostate cancer, head and neck cancer, and other cancers. This review article briefs about the role of Vitamin D in the prevention of cancer.

Keywords

Cancer - Vitamin D - Vitamin D3 (1 - 25-dihydroxycholecalciferol - calcitriol)

Publication History

Article published online:
23 June 2021

• References

• 1 Otten JJ, Hellwig JP, Meyers LD, Vitamin D. In: Dietary Reference intakes; The essential Guide to nutrient requirements. Washington DC: National Academies Press; 2006.
• 2 Institute of Medical standing Committee on the scientific evaluation of Dietary reference intakes. Vitamin D In: Dietary Reference Intakes: For calcium, Phosphorus, Magnesium, Vitamin D and Fluoride. Washington DC:National Academies Press; 1997.
• 3 Pilz S, Gaksch M, Hartaigh BÓ, Tomaschitz A, März W. Vitamin D in preventive medicine. Anticancer Res 2015; 35: 1161-70
• 4 Bidgoli SA, Azarsha BH. Role of vitamin deficiency and lack of sun exposure in the incidence of pre-menopausal breast cancer: a case control study in Sabzevar, Iran. Asian Pac Jou Cancer Prev 2014; 15: 3391-6
• 5 Jorde R, Grimnes G. Vitamin D and health: The need for more randomized controlled trials. J Steroid BiochemMolBiol 2015; 148: 269-74
• 6 Cashman KD. Vitamin D: dietary requirements and food fortification as a means of helping achieve adequate vitamin status. J Steroid Biochem Mol Biol 2015; 148: 19-26
• 7 Avenell A, MacLennan GS, Jenkinson DJ, McPherson GC, McDonald AM, Pant PR. et al. Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitaminD(3) and/or calcium(RECORDtrial). J Clin Endocrinol Metab 2012; 97: 614-22
• 8 Chiang KC, Chen TC. The anti-cancer actions of vitamin D. Anticancer Agents Med Chem 2013; 13: 126-39
• 9 Kennel KA, Drake MT. Vitamin D in the cancer patient. Curr Opin Support Palliat Care 2013; 7: 272-7
• 10 Alco G, Igdem S, Dincer M, Ozmen V, Saglam S, Selamoglu D. et al. Vitamin D levels in patients with breast cancer: importance of dressing style. Asian Pac J Cancer Prev 2014; 15: 1375-62
• 11 Ketha H, Wadams H, Lteif A, Singh RJ. Iatrogenic vitamin D toxicity in an infant–a case report and review of literature. J Steroid Biochem MolBiol 2015; 148: 14-8
• 12 Pilz S, Gaksch M, Hartaigh BÓ, Tomaschitz A, März W. Vitamin D in preventive medicine. Anticancer Res 2015; 35: 1161-70
• 13 Kiely M, Black LJ. Dietary strategies to maintain adequacy of circulating 25-hydroxy vitamin D concentrations. Scand J Clin Lab Invest Suppl 2012; 243: 14-23
• 14 Tuohimaa P, Lou YR. Optimal serum calcidiol concentration for cancer prevention. Anticancer Res 2012; 32: 373-81
• 15 Zoico E, Franceschetti G, Chirumbolo S, Rossi AP, Mazzali G, Rizzatti V. et al. Phenotypic shift of adipocytes by cholecalciferol and 1,25 dihydroxycholecal- ciferol in relation to inflammatory status and calcium content. Endocrinology 2014; 155: 4178-88
• 16 Bakdash G, vanCapel TM, Kapsenberg ML, DeJong EC. Vitamin D3 metabolite calcidiol primes human dendritic cells to promote the development of immunomodulatory IL-10 producing Tcells. Vaccine 2014; 32: 6294-302
• 17 Andrukhov O, Andrukhova O, Hulan U, Tang Y, Bantleon HP, Rausch- Fan X. Both 25-hydroxy vitamin-D3 and 1,25-dihydroxyvitamin-D3reduces inflammatory response in human periodontal ligament cells. PLoSOne 2014; 9: 30-37
• 18 Barry EL, Rees JR, Peacock JL, Mott LA, Amos CI, Bostick RM. et al. Genetic variants in CYP2R1, CYP24A1, and VDR modify the efficacy of vitaminD3 supplementation for increasing serum 25-hydroxy vitamin D levels in a randomized controlled trial. J Clin Endocrinol Metab 2014; 99: 2133-7
• 19 Rhieu SY, Annalora AJ, LaPorta E. Potent antiproliferative effects of 25-hydroxy-16-ene-23-yne-vitamin D3 that resists the catalytic activity of both CYP27B1 and CYP24A1. J CellBiochem 2014; 115: 1392-402
• 20 Kósa JP, Horváth P, Wölfling J, Kovács D, Balla B, Mátyus P. et al. CYP24A1 inhibition facilitates the anti-tumor effect of vitaminD3 on colorectal cancer cells. World J Gastroenterol 2013; 19: 2621-8
• 21 Clarke R, Newman C, Tomson J, Hin H, Kurien R, Cox J. et al. Estimation of the optimum dose of vitamin for disease prevention in older people: rationale, design and baseline characteristics of the BEST-D trial. Maturitas 2015; 80: 426-31
• 22 Barker T, Rogers VE, Levy M, Templeton J, Goldfine H, Schneider ED. et al. Supplemental vitamin increases serum cytokines in those with initially low 25-hydroxyvitaminD:a randomized, double blind, placebo-controlled study. Cytokine 2015; 71: 132-8
• 23 Aloia JF. Clinical review: The 2011 report on dietary reference intake for vitamin D: where do we go from here?. Endocrinol Metab 2011; 96: 2987-96
• 24 Walsh JE, Clark AM, Day TA, Gillespie MB, Young MR. Use of Alpha, 25-dihydroxy vitamin D3 treatment to stimulate immune infiltration in to head and neck squamous cell carcinoma. Hum Immunol 2010; 71: 659-65
• 25 Bothwell KD, Shaurova T, Merzianu M, Suresh A, Kuriakose MA, Johnson CS. et al. Impact of short term 1,25 (OH)2D3 on the chemopreventive efficacy of erlotinib against oral cancer. Cancer Prev Res 2015; 8: 765-76
• 26 Shrihari TG, Vijeev V, Soundarya K, Reddy D, Manjunath V, Devaraju D. Anti-inflammatory dietary supplements in the chemoprevention of cancer. Cancer Research frontiers 2016; 2: 380-395